Company Filing History:
1 out of 576 
1 out of 6 Years Active: 1995
Title: **Innovative Contributions of Inventor Jeffrey W. Clark in Tumor Treatment**
Introduction
Jeffrey W. Clark is an accomplished inventor based in Providence, Rhode Island. He holds a significant patent that demonstrates his innovative work in the field of tumor treatment. His invention focuses on the development of targeted therapeutic strategies for tumorigenic conditions, showcasing the potential of combining biological and chemical components to combat cancer effectively.
Latest Patents
Jeffrey W. Clark's notable patent is titled "Treatment of Tumorigenic Pathophysiological Conditions with FGF-Cytotoxic Conjugates." This patent describes the preparation of conjugates that comprise basic Fibroblast Growth Factor (bFGF) or other FGF polypeptides linked to a cytotoxic agent. The cytotoxic agent can be a ribosome-inactivating protein, such as saporin, which is chemically bonded to bFGF. Alternatively, these compositions can be structured as recombinant DNA chimeras. The conjugates specifically target cells expressing FGF receptors, allowing for a proportional increase in cytotoxicity based on receptor expression. This invention has promising applications in treating various tumor types, including melanomas, ovarian carcinomas, teratocarcinomas, neuroblastomas, and other tumorigenic conditions driven by FGF receptor proliferation.
Career Highlights
Throughout his career, Jeffrey W. Clark has made contributions to the fields of biology and oncology. He has worked at renowned institutions, including the Salk Institute for Biological Studies and Roger Williams General Hospital. His research efforts are focused on enhancing therapeutic approaches in cancer treatment and improving patient outcomes.
Collaborations
During his professional journey, Jeffrey W. Clark has collaborated with esteemed colleagues such as Paul Calabresi and Julie G. Beitz. These collaborations illustrate the importance of teamwork and knowledge-sharing in driving innovation and advancing treatment methodologies.
Conclusion
Jeffrey W. Clark's inventive work exemplifies the potential of targeted therapeutics in the fight against cancer. His patent on FGF-cytotoxic conjugates not only highlights his contributions to medical innovation but also promises a more effective approach to treating tumorigenic conditions. With continued research and collaboration, his work may pave the way for groundbreaking advancements in oncology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.